A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations
Conditions
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California Los Angeles Medical Center, Los Angeles, California, United States
Rady Children's Hospital, San Diego, California, United States
Nemours Children s Clinic, Jacksonville, Florida, United States
Nemours Childrens Hospital, Orlando, Florida, United States
Boston Children's Hospital - Main, Boston, Massachusetts, United States
Columbia University Irving Medical Center, New York, New York, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Seattle Children's Hospital, Seattle, Washington, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
University Hospital Tubingen, Tübingen, Germany
Shinshu University Hospital, Matsumoto-shi, Nagano, Japan
Clinica Universidad de Navarra- Pamplona, Pamplona, Navarre, Spain
Hospital Universitario Materno Infantil en las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
Ramon y Cajal University Hospital, Madrid, Spain
Addenbrooke's Hospital, Cambridge University Hospitals NHS FT, Cambridge, United Kingdom
Great Ormond Street Hospital For Children NHS Foundation Trust, London, United Kingdom
Study leads
Clinical Trial Management
Study Director
Regeneron Pharmaceuticals